Activity and damage in granulomatosis with polyangiitis

被引:10
作者
Yegin, Ender G. [1 ]
Can, Meryem [2 ]
Yilmaz, Neslihan [2 ]
Aydin, Sibel Z. [2 ]
Yavuz, Sule [2 ]
Tuglular, Serhan [3 ]
Direskeneli, Haner [2 ]
机构
[1] Marmara Univ, Dept Internal Med, Fac Med, Istanbul, Turkey
[2] Marmara Univ, Dept Rheumatol, Fac Med, Istanbul, Turkey
[3] Marmara Univ, Dept Nephrol, Fac Med, Istanbul, Turkey
关键词
activity; damage; granulomatosis with polyangiitis; WEGENERS-GRANULOMATOSIS; MICROSCOPIC POLYANGIITIS; SYSTEMIC VASCULITIS; PULSE CYCLOPHOSPHAMIDE; PROGNOSTIC-FACTORS; RANDOMIZED-TRIAL; PLASMA-EXCHANGE; RELAPSE; INDEX; PREDICTORS;
D O I
10.1111/1756-185x.12022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim To retrospectively analyze disease activity and damage-associated factors in granulomatosis with polyangiitis (GPA) in Turkey. Method A retrospective analysis was carried out in 21 GPA patients. Assessments for activity were performed with the Birmingham Vasculitis Activity Score for GPA (BVAS/GPA) and for permanent organ damage by the Vasculitis Damage Index (VDI). Results Lower BVAS/GPA (P=0.002), absence of renal involvement (P=0.003) and higher creatinine clearence (P=0.000) at diagnosis increased the likelihood of achieving remission at 6weeks. Relapses were associated with high creatinine clearence (P=0.021), low BVAS/GPA (P=0.014), absence of renal involvement (P=0.036) and proteinuria (<0.5/24h) (P=0.013) at diagnosis, whereas achieving remission at 6weeks (P=0.012) was associated with absence of co-trimoxazole usage (P=0.038) and less severe clinical subgroup (P=0.034). Lower cumulative first 6months of cyclophosphamide and methylprednisolone were associated with earlier (12months) relapses (P=0.048 and P=0.083, respectively). Baseline damage (VDI1) was associated with a delay in diagnosis (P=0.032), presentation with milder clinical subgroups (P=0.052) and low serum creatinine (P=0.013). The increase in VDI in the first 12months (early damage) constituted most (91%) of the total damage measured at the end of follow-up. Conclusions Despite high early remission rates, relapse represents a major problem in localized GPA in our study. Baseline damage was associated with longer diagnostic delay and lower baseline serum creatinine. The initial phase of the disease seems to be the most crucial period for mortality and accumulated damage.
引用
收藏
页码:61 / 71
页数:11
相关论文
共 50 条
  • [1] Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis
    Weiner, Maria
    Goh, Su Mein
    Mohammad, Aladdin J.
    Hruskova, Zdenka
    Tanna, Anisha
    Sharp, Phoebe
    Kang, Amy
    Bruchfeld, Annette
    Selga, Daina
    Chocova, Zdenka
    Westman, Kerstin
    Eriksson, Per
    Harper, Lorraine
    Pusey, Charles D.
    Tesar, Vladimir
    Salama, Alan D.
    Segelmark, Marten
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (04) : 580 - 588
  • [2] Rituximab Maintenance Therapy for Granulomatosis with Polyangiitis and Microscopic Polyangiitis
    Roubaud-Baudron, Claire
    Pagnoux, Christian
    Meaux-Ruault, Nadine
    Grasland, Anne
    Zoulim, Abdelkader
    Le Guen, Julien
    Prud'Homme, Anne
    Bienvenu, Boris
    de Menthon, Mathilde
    Camps, Sandra
    Le Guern, Veronique
    Aouba, Achille
    Cohen, Pascal
    Mouthon, Luc
    Guillevin, Loic
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (01) : 125 - 130
  • [3] Maintaining remission in patients with granulomatosis with polyangiitis or microscopic polyangiitis: the role of ANCA
    Kemna, Michael J.
    van Paassen, Pieter
    Damoiseaux, Jan G. M. C.
    Tervaert, Jan Willem Cohen
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (03): : 207 - 218
  • [4] Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis
    Berti, Advise
    Cornec, Divi
    Dua, Anisha B.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2023, 49 (03) : 545 - 561
  • [5] Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual
    Delvino, Paolo
    Sardanelli, Federica
    Monti, Sara
    Cohen, Pascal
    Puechal, Xavier
    Mouthon, Luc
    Montecucco, Carlomaurizio
    Guillevin, Loic
    Terrier, Benjamin
    ARTHRITIS CARE & RESEARCH, 2023, 75 (05) : 1158 - 1165
  • [6] Granulomatosis with Polyangiitis and Microscopic Polyangiitis
    Klapa, Sebastian
    Arnold, Sabrina
    Lamprecht, Peter
    AKTUELLE RHEUMATOLOGIE, 2023, 48 (01) : 60 - 69
  • [7] Granulomatosis with polyangiitis and microscopic polyangiitis
    Klapa, Sebastian
    Arnold, Sabrina
    Lamprecht, Peter
    LARYNGO-RHINO-OTOLOGIE, 2024, 103 (07) : 490 - 499
  • [8] Epidemiology and genetics of granulomatosis with polyangiitis
    Banerjee, Pratibha
    Jain, Arushi
    Kumar, Uma
    Senapati, Sabyasachi
    RHEUMATOLOGY INTERNATIONAL, 2021, 41 (12) : 2069 - 2089
  • [9] Cardiac Involvement in Granulomatosis with Polyangiitis
    McGeoch, Lucy
    Carette, Simon
    Cuthbertson, David
    Hoffman, Gary S.
    Khalidi, Nader
    Koening, Curry L.
    Langford, Carol A.
    McAlear, Carol A.
    Moreland, Larry
    Monach, Paul A.
    Seo, Philip
    Specks, Ulrich
    Ytterberg, Steven R.
    Merkel, Peter A.
    Pagnoux, Christian
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1209 - 1212
  • [10] Wegener Granulomatosis (Granulomatosis with Polyangiitis): Evolving Concepts in Treatment
    Lynch, Joseph P., III
    Tazelaar, Henry
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 32 (03) : 274 - 297